2023 - Enhancing and Prolonging Drug Delivery to the Eye
 Recording Link - available soon |
|
| Introduction | Sean P. Donahue, MD, PhD |
| Enhancing Topical Drug Delivery through Biomaterials | Justin Hanes, PhD |
| Suprachoroidal Cannulation and Micro-needle Delivery | Timothy W. Olsen, MD |
| Gene Therapy Delivery for Age-related Macular Degeneration | Jacque L. Duncan, MD |
| Port Delivery System and Other Intraocular Storage Devices | Baruch D. Kuppermann, MD, PhD |
| Polymeric Nanoparticles, Microparticles, Hydrogels, and Nanopore Films | Jennifer Kang-Mieler, PhD |
| Intra-arterial Drug Delivery for Ocular Cancers | Jasmine Francis, MD |
2022 - The New Normal of Genetics in Ophthalmology
| Recording Link - available soon |
|
| Introduction | Peter A. Netland, MD |
| Gene Therapy | Edwin M. Stone, MD, PhD |
| Gene-Based Approaches to AMD | Bradley D. Gelfand, PhD |
| Gene-Directed Therapy | John H. Fingert, MD, PhD FARVO |
| Genetics in Glaucoma | Janey L. Wiggs, MD, PhD |
| Epigenetic Therapy | Cheryl Y. Gregory-Evans, PhD |
| Gene-Based Prognosis and Beyond in Ocular Oncology | J. William Harbour, MD |
2021 - COVID-19 - What We Thought We Knew, What We Learned, and Future Strategies
| Recording Link |
|
| Introduction | Jayne S. Weiss, MD |
| Global Clinical Ophthalmology and COVID-19 - What We Can Learn from Australia and New Zealand | Hugh R. Taylor, AC, MD, FRAC |
| Managing an Ophthalmology Department/Practice During a Pandemic | Stephen D. McLeod, MD |
| The Post COVID Virtual World - Telemedicine, CME, and Certification | Michael F. Chiang, MD |
| Eye Findings in COVID-19 | Anat Galor, MD, MSPH |
2020 - Opsin Ecology: The Evolution, Function and Diseases of Visual and Non-visual Pigments
| Recording Link - available summer 2020 |
|
| Introduction | Ivan Schwab, MD |
| Opsins Make Sense | Alfred Wallace |
| Opsins in the Metazoan World | Tom Cronin, PhD |
| Human Opsins in the Eye | Jay Neitz, PhD |
| Clinical Disease and Treatment | Alfredo Sadun, MD, PhD |
2019 - Ocular Inflammation: Putting Out Fire
| Recording Link |
|
| Introduction | Preston Blomquist, MD |
| Advanced Ocular Imaging in the Management of Uveitis | Quan Dong Nguyen, MD, MSc |
| Evidence-based Treatment for Noninfectious Uveitis | Douglas Jabs, MD, MBA |
| New Directions for Treatment of Ocular Inflammation | Janet Davis, MD |
| The Gut Microbiome and its Relation to Ocular Inflammation | Jerry Niederkorn, PhD |
2018 - Wound Healing and the Cornea
| Recording Link |
|
| Introduction | Eduardo Alfonso, MD |
| The Regenerated Cornea | May Griffith, PhD |
| Corneal Nerve Regeneration | Mark Rosenblatt, MD, PhD, MBA |
| Conjunctival Repair (Pterygium) | Lawrence Hirst, DO, MPH, MD, DSc, FRANZCO, FRACS |
| Epithelial Repair (Limbal Transplant) | Edward Holland, MD |
| Stromal Remodeling (Cross-Linking) | Peter Hersh, MD |
| Endothelial Cell Repair | Shigeru Kinoshita, MD |
2017 - Optic Nerve Regeneration and Reconnection: Current Status, Challenges and Audacious Future Goals
| Recording Link |
|
| Introduction | David T. Tse, MD |
| RGC Types Differ in Function and in Vulnerability to Disease | Joshua R. Sanes, PhD |
| Progress and Challenges in RGC Protection | Harry Quigley, MD |
| Challenges in Axon Pathfinding and Target Recognition | Kevin K. Park, PhD |
| Progress and Challenges in Axon Regeneration | Zhigang He, PhD |
2016 - Innovative Paradigm Shifts in Ophthalmology
| Recording Link |
|
| Introduction | J. Sebag, MD |
| Phenotype vs. Genotype: What Inherited Diseases Foretell About Tomorrow's Definition of Disease | Eric Pierce, MD, PhD |
| Beyond Visual Acuity: New Paradigms of Measuring Vision | Alfredo A. Sadun, MD, PhD |
| From Space to Earth: Nanoimaging for Earlier Detection of Eye Disease | Rafat R. Ansari, PhD |
| The Evolution of Therapeutics in Ophthalmology | Jean-Marie A. Parel, Ing ETS-D, PhD |
2015 - Innovations in Medical Education
| Recording Link |
|
| Introduction | J. Sebag, MD |
| What Happened to my Medical School? | Edward G. Buckley, MD |
| Creating Future Leaders | Darrell G. Kirch, MD |
| Transforming Resident Education | Benjamin A. Alman, MD |
| Health Care Social Media and Digital Identity for Ophthalmology: Opportunity, Risk and Reward | Farris K. Timimi, MD |
| Educating the World’s Ophthalmologists | Bruce E. Spivey, MD |
2014 - Ocular Gene Therapy
| Recording Link |
|
| Introduction of Verhoeff Lecture | David Wilson, MD |
| The Rocky Road to Successful Human Gene Therapy (Verhoeff Lecture) | J. Timothy Stout, MD |
| Introduction of AOS-Knapp Symposium | Edward Buckley, MD |
| Introduction of Genetic Eye Disease | Edwin Stone, MD, PhD |
| Gene Replacement Therapy | Albert Maguire, MD |
| Pharmacologic Delivery with Gene Therapy | Peter Campochiaro, MD |
| Gene Therapy vs. Stem Cell Therapy | Marco Zarbin, MD, PhD |
| Risks of Gene Therapy | Paul Sieving, MD, PhD |
| Ethical Considerations in Gene Therapy | Alex Levin, MD, MHSc |
2013 - Challenges of Ophthalmic Care in the Developing World
| Recording Link |
|
| Introduction | Stephen D. McLeod, MD |
| Preventing Blindness & Child Mortality with Vitamin A: an AOS Odyssey (Verhoeff Lecture) | Alfred Sommer, MD |
| Overview of Major Challenges & the Vision 20/20 Initiative | Hugh R. Taylor, AC, MD, FRACS |
| Trachoma Prevention & Treatment | Sheila West, PhD, PharmD |
| Corneal Blindness & Infectious Keratitis | Thomas M. Lietman, MD |
| CMV Retinitis | Jeremy Keenan, MD, MPH |
| A Systems Approach to Cataract Blindness | Ravilla D. Thulasiraj, BSc, MBA |
| Retinopathy of Prematurity in the Developing World | Michael Chiang, MD |
2012 - Nanotechnology in Ophthalmology
| Introduction | Mark W. Johnson, MD |
| Brief Overview of Nanomedicine Nanosurgery & Molecules as Machines |
Marco A. Zarbin, MD, PhD |
| Delivery of Drugs, Peptides, and Genes | Uday Kompella, PhD |
| Imaging and Diagnostics | Edward M. Barnett, MD, PhD |
| Regenerative Medicine and Prosthetics | James F. Leary, PhD |
| Biosensing/Health Maintenance | Raymond Iezzi, MD |
| Molecular Engineering | John G. Flannery, PhD |
2011 - The Ophthalmologist of the Future
| Introduction | Ronald L. Gross, MD |
| Health Policy | William L. Rich, III, MD |
| Patient Care Guidelines | Paul P. Lee, MD, JD |
| Electronic Medical Records | Joel S. Schuman, MD |
| Ophthalmic Associations | Ruth D. Williams, MD |
| Generational Issues | Ann Brown, MD, MHS |
| Communications | Andrew P. Doan, MD, PhD |
2010 - Managing Presbyopia: How Far Have We Come?
| Introduction | Steven E. Feldon MD |
| Physiology of Accommodation and Pathogenesis of Presbyopia (Verhoeff Lecture) | Adrian Glasser PhD |
| Optics of Current Technology: Accommodation or Pseudoaccommodation? | Geunyoung Yoon PhD |
| Pseudophakic Approaches to Correcting Presbyopia | Roger F. Steinert MD |
| Corneal Approaches to Correcting Presbyopia | Richard L. Lindstrom MD |
| What Lies Ahead? | Douglas D. Koch MD |
2009 - Advanced Imaging in Ophthalmology
| Introduction | Marco A. Zarbin MD PhD |
| Adaptive Optics | Edward N. Pugh Jr. PhD Jacque L. Duncan MD |
| Motion-Sensitive OCT | Daniel M. Schwartz MD |
| Spectral Domain OCT | Carmen A. Puliafito MD MBA |
| Glaucoma Imaging | Robert N. Weinreb MD |
| Neuroimaging | Andrew G. Lee MD |
2008 - Ethics of Industry-Ophthalmologist Relationships
| Introductory Comments, Misbehaviors: Observations of a Long Term Department Chair | Lee Jampol MD |
| What is the Current Status of Individual and Institutional Conflict of Interest? | Michael Camilleri MD |
| How Should Academic Institutions Behave with Regard to Industry? | Jordan Cohen MD |
| How Should Individual Faculty Respond to Industry Relationships? | Susan Day MD |
| How Should Practicing Ophthalmologists Respond to Industry Largesse? | Richard Mills MD MPH |
| How can Professional Organizations Justify Receiving Corporate Funding for Organizational Activities? | Jerome Kassirer MD |
| Ethical Alignment? Physicians and Their Professional Organizations | Samuel Packer MD |
2007 - Angiogenesis: From Concept to Clinic
| Introductory Comments | Jayakrishna Ambati MD and Richard P. Mills MD |
| Ocular Antiangiogenesis: Past, Present, and Future | Anthony Adamis MD |
| Unlocking the Mystery of Corneal Avascularity | Balamurali Ambati MD |
| Angiogenesis and Diabetic Retinopathy in 2007 | Neil M. Bressler MD |
| Medical Treatment for Retinopathy of Prematurity: Bench to Bedside | Lois E. H. Smith MD PhD |
| Inflammation and Angiogenesis in Age-Related Macular Degeneration | Jayakrishna Ambati MD |
2006 - Wavefront Technology and the Quest for Super Vision
| Wavefront Basics: Measuring and Quantifying | Raymond Applegate OD PhD |
| Corneal Optics and Biomechanics | Cynthia Roberts PhD |
| The Complex Role of the Crystalline Lens | Adrian Glasser PhD |
| Clinical Realities | Scott M McRae MD |
2005 - Tissue Bioengineering and Regenerative Medicine
| Tissue Engineering - Basic Concepts | Don Feng Chen PhD |
| Biocompatibility: Old and New Paradigms | Buddy D. Ratner PhD |
| Tubes, Scaffolds and Guided Regeneration | Molly Schoichet PhD |
| Amyotrophic Lateral Sclerosis: Lou Gehrig Disease | Michael J. Young PhD |
2004 - Targeted Drug Delivery in Ophthalmology
| New Ways to Achieve Therapeutic Drug Levels in the Vitreous and Retina | Henry F. Edelhauser PhD |
| Transscleral Drug Delivery to the Retina and Choroid | Anthony P. Adamis MD |
| Principles of Posterior Segment Drug Delivery: Fluocinolone Acetonide Sustained Drug Delivery System to Treat Retinal Vascular Disease | Glenn J. Jaffe MD |
| Variables in Transscleral Drug Delivery | Timothy Olsen MD |
| Cytoskeletal, Cell Adhesion, and Cell Contractility in the Trabecular Meshwork as Targets for Glaucoma Therapy | Paul L. Kaufman MD |
2003 - Ocular Genetics
| How Molecular Genetics is Lifting the Fog: The Etiology of Retinitis Pigmentosa (Verhoeff Lecture) | Thaddeus P. Dryja MD |
| Current Research in Retinoblastoma | Joan O’Brien MD |
| Glaucoma Genetics | Janey L. Wiggs MD PhD |
| Genetics of Macular Degeneration | Edwin Stone MD PhD |
2002 - Stem Cells: What Are They and How Might They Be Used for Ocular Disease Treatment?
| How Many Photoreceptors Do We Need for Vision? (Verhoeff Lecture) | Paul A. Sieving MD PhD |
| Introduction to Epithelial Stem Cells: The Eye Shows the Way | Robert Lavker PhD |
| Clinical Aspects of Ocular Surface Stem Cell Transplantation | Edward Holland MD |
| Retinal Stem Cells? Current Status and Future Possibilities | Pamela Raymond PhD |